ZVSA
Price:
$0.14
Market Cap:
$1.13M
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
Industry
Biotechnology
IPO Date
2022-02-11
Stock Exchange
NASDAQ
Ticker
ZVSA
According to ZyVersa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.08. This represents a change of -30.65% compared to the average of 0.11 of the last 4 quarters.
The mean historical Current Ratio of ZyVersa Therapeutics, Inc. over the last ten years is 0.27. The current 0.08 Current Ratio has changed 2.76% with respect to the historical average. Over the past ten years (40 quarters), ZVSA's Current Ratio was at its highest in in the September 2024 quarter at 33.83. The Current Ratio was at its lowest in in the March 2021 quarter at 0.00.
Average
0.27
Median
0.15
Minimum
0.04
Maximum
0.78
Discovering the peaks and valleys of ZyVersa Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.20%
Maximum Annual Current Ratio = 0.78
Minimum Annual Increase = -57.67%
Minimum Annual Current Ratio = 0.04
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.15 | -53.55% |
| 2023 | 0.33 | -57.67% |
| 2022 | 0.78 | 1.20% |
| 2021 | 0.06 | 32.75% |
The current Current Ratio of ZyVersa Therapeutics, Inc. (ZVSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.42
5-year avg
0.27
10-year avg
0.27
ZyVersa Therapeutics, Inc.’s Current Ratio is less than Hepion Pharmaceuticals, Inc. (7.60), less than CDT Equity Inc. (1.66), less than Enveric Biosciences, Inc. (2.43), less than Longevity Health Holdings Inc. (0.42), less than NewGenIvf Group Limited (1.17), less than SCWorx Corp. (1.13), less than Indaptus Therapeutics, Inc. (0.75), less than Jasper Therapeutics, Inc. (2.10), less than Onconetix, Inc. (0.08), less than Silexion Therapeutics Ltd. (2.44),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.60 | $697.22K | |
| 1.66 | $2.46M | |
| 2.43 | $3.65M | |
| 0.42 | $548.98K | |
| 1.17 | $544.91K | |
| 1.13 | $1.01M | |
| 0.75 | $3.75M | |
| 2.10 | $30.23M | |
| 0.08 | $1.68M | |
| 2.44 | $1.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZyVersa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ZyVersa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ZyVersa Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the highest Current Ratio for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the 3-year average Current Ratio for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the 5-year average Current Ratio for ZyVersa Therapeutics, Inc. (ZVSA)?
How does the current Current Ratio for ZyVersa Therapeutics, Inc. (ZVSA) compare to its historical average?